The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
CODE
1 other identifier
observational
613
1 country
1
Brief Summary
This study is going to apply neuropsychological battery tests to measure cognitive function across multiple cognitive domains in our cohort of 600 maintenance hemodialysis patients and evaluate:
- 1.The presence and patterns of cognitive impairment in domains of executive function, perceptual-motor function, language, learning and memory, and complex attention;
- 2.Clinical characteristics of participants with and without cognitive impairment;
- 3.the risk factors which might be related to cognitive impairment in this group of population;
- 4.The association between cognitive impairment and all-cause mortality, stroke and non-fatal cardiovascular events;
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2017
CompletedFirst Posted
Study publicly available on registry
August 16, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2019
CompletedJuly 12, 2019
July 1, 2019
1.8 years
August 14, 2017
July 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
cognitive function
This study is going to apply neuropsychological battery tests to measure cognitive function across multiple cognitive domains
This measurement is going to be completed within 3 months after the first participant enrolls.
Study Arms (2)
Normal cognitive function
The cognitive impairment classification algorithm We classified subjects as having no, mild, or major cognitive impairment using criteria from the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as a guideline.20 The age and/or education-adjusted raw score of each individual cognitive test was calculated and compared with the age and/or education-adjusted published norms for Chinese populations.14 Specifically, age- and education-adjusted scores less than 1.5 standard deviations (SDs) below the adjusted mean of the published population norms on all tests in all domains indicated no cognitive impairment; scores of 1.50 to 1.99 SDs and 2.0 or more SDs below the adjusted mean of the published norms on at least one test in at least one domain indicated mild cognitive impairment and major cognitive impairment, respectively
cognitive impairment
The cognitive impairment classification algorithm We classified subjects as having no, mild, or major cognitive impairment using criteria from the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as a guideline.20 The age and/or education-adjusted raw score of each individual cognitive test was calculated and compared with the age and/or education-adjusted published norms for Chinese populations.14 Specifically, age- and education-adjusted scores less than 1.5 standard deviations (SDs) below the adjusted mean of the published population norms on all tests in all domains indicated no cognitive impairment; scores of 1.50 to 1.99 SDs and 2.0 or more SDs below the adjusted mean of the published norms on at least one test in at least one domain indicated mild cognitive impairment and major cognitive impairment, respectively
Interventions
one are of patients were exposed to cognitive impairment
Eligibility Criteria
Chinese Maintenace Hemodialysis Patients
You may qualify if:
- Subjects have end-stage kidney disease and are treated with long-term outpatient haemodialysis in each investigational site for at least the previous 3 months;
- \~ 80 years old;
- willing to provide written and informed consent.
You may not qualify if:
- Subjects have disturbance of consciousness or mental disorder;
- Subjects have sensory (visual and hearing) or motor impairment, which disabled them to complete the tests that required these senses;
- Subjects have a life expectancy less than 6 months according to their physician, have a planned kidney transplantation within 6 months of baseline, or have anticipated recovery of kidney function.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Shijitan Hospital affiliated to Capital Medical University
Beijing, 100038, China
Related Publications (1)
Tian R, Bai Y, Guo Y, Ye P, Luo Y. Association Between Sleep Disorders and Cognitive Impairment in Middle Age and Older Adult Hemodialysis Patients: A Cross-Sectional Study. Front Aging Neurosci. 2021 Dec 8;13:757453. doi: 10.3389/fnagi.2021.757453. eCollection 2021.
PMID: 34955811DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yang Luo, MD, PhD
Beijing Shijitan Hospital Affiliated to Capital Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of nephrology
Study Record Dates
First Submitted
August 14, 2017
First Posted
August 16, 2017
Study Start
September 1, 2017
Primary Completion
June 18, 2019
Study Completion
June 18, 2019
Last Updated
July 12, 2019
Record last verified: 2019-07